Starting in July of this year, China initiated a patent registration platform that bears some similarity to the generic drug framework under the Hatch-Waxman Act in the U.S. The purpose of this alert is to describe this new...more
As a follow-up to our Wilson Sonsini Alert on March 23, 2020, which discussed the United States Patent and Trademark Office's (USPTO's) response to the COVID-19 update, today we are providing a summary of the response from...more